Indicators

Latest News about Eli Lilly And Co

Recent news which mentions Eli Lilly And Co

< Previous 1 2 3 4 5 6 7 8 9

...

Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug

June 11, 2024

FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval

June 10, 2024

Jim Cramer's week ahead: Fed meeting and CPI report

June 07, 2024

Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big

June 07, 2024

Alphabet's new CFO was in the middle of the GLP-1 boom. Now she's onto generative AI

June 06, 2024

Alphabet taps Eli Lilly's Anat Ashkenazi as new CFO

June 05, 2024

Why half of all workers may struggle to get weight-loss drug health insurance coverage

May 30, 2024

Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages

May 29, 2024

This new weight loss drug ETF bets big on two of the industry's leading players

May 27, 2024

How digital health companies are capitalizing on the GLP-1 boom

May 25, 2024

Eli Lilly to invest another $5.3 billion in Indiana plant to expand Mounjaro, Zepbound supply

May 24, 2024

Cramer's Lightning Round: Sigma Lithium is 'too dicey'

May 23, 2024

This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A

May 23, 2024

Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins

May 21, 2024

Roche says weight loss drug shows promising results in early trial

May 16, 2024

Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says

May 14, 2024

People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says

May 14, 2024

Google's Demis Hassabis is the man tasked with turning bleeding-edge AI research into profits

May 13, 2024

Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply

May 07, 2024

Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance

May 07, 2024

Within a few years, generative AI will be designing new drugs all on its own

May 05, 2024

Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide

May 03, 2024

Wegovy maker Novo Nordisk down 4%, heads for worst day since October

May 03, 2024

Amgen scraps experimental weight loss pill, moves forward with injection

May 02, 2024

Eli Lilly beats on quarterly profit, hikes full-year guidance on strong sales of Zepbound, Mounjaro

April 30, 2024

5 things to know before the stock market opens Monday

April 29, 2024

Cramer's week ahead: Fed meeting and earnings from Apple, Amazon, Eli Lilly

April 26, 2024

Most people on weight loss drugs are spending less on restaurants and takeout, survey says

April 20, 2024

Most doses of Eli Lilly's Zepbound, Mounjaro in short supply through June, FDA says

April 17, 2024

Eli Lilly’s Zepbound shows promise as a sleep apnea treatment in late-stage trials

April 17, 2024

< Previous 1 2 3 4 5 6 7 8 9

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.